|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US5139941A
(en)
|
1985-10-31 |
1992-08-18 |
University Of Florida Research Foundation, Inc. |
AAV transduction vectors
|
|
US5436146A
(en)
|
1989-09-07 |
1995-07-25 |
The Trustees Of Princeton University |
Helper-free stocks of recombinant adeno-associated virus vectors
|
|
US7101993B1
(en)
|
1990-01-11 |
2006-09-05 |
Isis Pharmaceuticals, Inc. |
Oligonucleotides containing 2′-O-modified purines
|
|
US6268213B1
(en)
|
1992-06-03 |
2001-07-31 |
Richard Jude Samulski |
Adeno-associated virus vector and cis-acting regulatory and promoter elements capable of expressing at least one gene and method of using same for gene therapy
|
|
US5478745A
(en)
|
1992-12-04 |
1995-12-26 |
University Of Pittsburgh |
Recombinant viral vector system
|
|
US5869305A
(en)
|
1992-12-04 |
1999-02-09 |
The University Of Pittsburgh |
Recombinant viral vector system
|
|
EP0682717A4
(en)
|
1993-02-05 |
1997-04-23 |
Laporte Group Australia |
ANTI-FOAMING COMPOSITE FOR DAIRY.
|
|
US20020173474A1
(en)
|
1993-02-12 |
2002-11-21 |
President And Fellows Of Harvard College |
Methods & materials involving dimerization-mediated regulation of biological events
|
|
US5869337A
(en)
|
1993-02-12 |
1999-02-09 |
President And Fellows Of Harvard College |
Regulated transcription of targeted genes and other biological events
|
|
US6063625A
(en)
|
1993-02-12 |
2000-05-16 |
Board Of Trustees Of Leland S, Stanford, Jr. University |
Regulated transcription of targeted genes and other biological events
|
|
US5830462A
(en)
|
1993-02-12 |
1998-11-03 |
President & Fellows Of Harvard College |
Regulated transcription of targeted genes and other biological events
|
|
US5834266A
(en)
|
1993-02-12 |
1998-11-10 |
President & Fellows Of Harvard College |
Regulated apoptosis
|
|
FI953812A0
(fi)
|
1993-02-12 |
1995-08-11 |
Univ Leland Stanford Junior |
Kohdistettujen geenien säädelty transkriptio ja muita biologisia toimintoja
|
|
US6972193B1
(en)
|
1993-02-12 |
2005-12-06 |
Board Of Trustees Of Leland Stanford Junior University |
Regulated transcription of targeted genes and other biological events
|
|
US6150137A
(en)
|
1994-05-27 |
2000-11-21 |
Ariad Pharmaceuticals, Inc. |
Immunosuppressant target proteins
|
|
US6476200B1
(en)
|
1994-06-27 |
2002-11-05 |
The Johns Hopkins University |
Mammalian proteins that bind to FKBP12 in a rapamycin-dependent fashion
|
|
US6204059B1
(en)
|
1994-06-30 |
2001-03-20 |
University Of Pittsburgh |
AAV capsid vehicles for molecular transfer
|
|
US6133456A
(en)
|
1994-08-18 |
2000-10-17 |
Ariad Gene Therapeutics, Inc. |
Synthetic multimerizing agents
|
|
AU3367995A
(en)
|
1994-08-18 |
1996-03-14 |
Ariad Pharmaceuticals, Inc. |
New multimerizing agents
|
|
US6150527A
(en)
|
1994-08-18 |
2000-11-21 |
Ariad Pharmaceuticals, Inc. |
Synthetic multimerizing agents
|
|
US5786464C1
(en)
|
1994-09-19 |
2012-04-24 |
Gen Hospital Corp |
Overexpression of mammalian and viral proteins
|
|
US6326166B1
(en)
|
1995-12-29 |
2001-12-04 |
Massachusetts Institute Of Technology |
Chimeric DNA-binding proteins
|
|
WO1996020951A1
(en)
|
1994-12-29 |
1996-07-11 |
Massachusetts Institute Of Technology |
Chimeric dna-binding proteins
|
|
US6166197A
(en)
|
1995-03-06 |
2000-12-26 |
Isis Pharmaceuticals, Inc. |
Oligomeric compounds having pyrimidine nucleotide (S) with 2'and 5 substitutions
|
|
US5811524A
(en)
|
1995-06-07 |
1998-09-22 |
Idec Pharmaceuticals Corporation |
Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
|
|
US6187757B1
(en)
|
1995-06-07 |
2001-02-13 |
Ariad Pharmaceuticals, Inc. |
Regulation of biological events using novel compounds
|
|
US6093570A
(en)
|
1995-06-07 |
2000-07-25 |
The University Of North Carolina At Chapel Hill |
Helper virus-free AAV production
|
|
US6506379B1
(en)
|
1995-06-07 |
2003-01-14 |
Ariad Gene Therapeutics, Inc. |
Intramuscular delivery of recombinant AAV
|
|
CA2219080A1
(en)
|
1995-06-07 |
1996-12-27 |
Ariad Gene Therapeutics, Inc. |
Rapamycin-based regulation of biological events
|
|
US5741683A
(en)
|
1995-06-07 |
1998-04-21 |
The Research Foundation Of State University Of New York |
In vitro packaging of adeno-associated virus DNA
|
|
CA2244363C
(en)
|
1996-02-28 |
2006-11-14 |
Ariad Gene Therapeutics, Inc. |
Synthetic derivatives of rapamycin as multimerizing agents for chimeric proteins with immunophilin-derived domains
|
|
US6723531B2
(en)
|
1996-04-05 |
2004-04-20 |
The Salk Institute For Biological Studies |
Method for modulating expression of exogenous genes in mammalian systems, and products related thereto
|
|
US6258823B1
(en)
|
1996-07-12 |
2001-07-10 |
Ariad Pharmaceuticals, Inc. |
Materials and method for treating or preventing pathogenic fungal infection
|
|
EP2327797B1
(en)
|
1997-04-01 |
2015-11-25 |
Illumina Cambridge Limited |
Method of nucleic acid sequencing
|
|
US6548286B1
(en)
|
1997-04-14 |
2003-04-15 |
Cell Genesys, Inc. |
Methods for increasing the efficiency of recombinant AAV product
|
|
US6015709A
(en)
|
1997-08-26 |
2000-01-18 |
Ariad Pharmaceuticals, Inc. |
Transcriptional activators, and compositions and uses related thereto
|
|
US6117680A
(en)
|
1997-08-26 |
2000-09-12 |
Ariad Gene Therapeutics, Inc. |
Compositions and methods for regulation of transcription
|
|
US6479653B1
(en)
|
1997-08-26 |
2002-11-12 |
Ariad Gene Therapeutics, Inc. |
Compositions and method for regulation of transcription
|
|
JP2001514007A
(ja)
|
1997-08-27 |
2001-09-11 |
アリアド ジーン セラピューティクス インコーポレイテッド |
キメラ転写アクチベーター、ならびにそれに関連する組成物および使用
|
|
AU755784B2
(en)
|
1998-01-15 |
2002-12-19 |
Ariad Pharmaceuticals, Inc. |
Regulation of biological events using multimeric chimeric proteins
|
|
US6984635B1
(en)
|
1998-02-13 |
2006-01-10 |
Board Of Trustees Of The Leland Stanford Jr. University |
Dimerizing agents, their production and use
|
|
EP1053241A1
(en)
|
1998-02-13 |
2000-11-22 |
President And Fellows Of Harvard College |
Novel dimerizing agents, their production and use
|
|
US6333318B1
(en)
|
1998-05-14 |
2001-12-25 |
The Salk Institute For Biological Studies |
Formulations useful for modulating expression of exogenous genes in mammalian systems, and products related thereto
|
|
EP1080218A1
(en)
|
1998-05-27 |
2001-03-07 |
University of Florida |
Method of preparing recombinant adeno-associated virus compositions by using an iodixanol gradient
|
|
US6258603B1
(en)
|
1998-06-17 |
2001-07-10 |
Rohm And Haas Company |
Ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
|
|
US6210892B1
(en)
|
1998-10-07 |
2001-04-03 |
Isis Pharmaceuticals, Inc. |
Alteration of cellular behavior by antisense modulation of mRNA processing
|
|
US6200560B1
(en)
|
1998-10-20 |
2001-03-13 |
Avigen, Inc. |
Adeno-associated virus vectors for expression of factor VIII by target cells
|
|
US6221349B1
(en)
|
1998-10-20 |
2001-04-24 |
Avigen, Inc. |
Adeno-associated vectors for expression of factor VIII by target cells
|
|
US7109317B1
(en)
|
1998-11-06 |
2006-09-19 |
President And Fellows Of Harvard College |
FK506-based regulation of biological events
|
|
ATE454445T1
(de)
|
1998-11-10 |
2010-01-15 |
Univ North Carolina |
Virusvektoren und verfahren für ihre herstellung und verabreichung.
|
|
ATE403715T1
(de)
|
1999-08-09 |
2008-08-15 |
Targeted Genetics Corp |
Erhöhung der expression einer einzelsträngigen, heterologen nukleotidsequenz von einem rekombinanten viralen vektor durch ausgestaltung der sequenz in einer art und weise, dass basenpaarungen innerhalb der sequenz entstehen
|
|
US7067526B1
(en)
|
1999-08-24 |
2006-06-27 |
Ariad Gene Therapeutics, Inc. |
28-epirapalogs
|
|
ES2219388T3
(es)
|
1999-08-24 |
2004-12-01 |
Ariad Gene Therapeutics, Inc. |
28-epi-rapalogos.
|
|
US6780639B1
(en)
|
1999-08-24 |
2004-08-24 |
Universite Libre De Bruxelles |
Antibiotic inducible/repressible genetic construct for gene therapy or gene immunization
|
|
JP3961737B2
(ja)
|
2000-02-29 |
2007-08-22 |
株式会社小糸製作所 |
車両用灯具およびその製造方法
|
|
US20040033600A1
(en)
|
2001-03-21 |
2004-02-19 |
Palli Subba Reddy |
Ecdysone receptor-based inducible gene expression system
|
|
AU2001249315A1
(en)
|
2000-03-22 |
2001-10-03 |
Rheogene, Inc. |
Ecdysone receptor-based inducible gene expression system
|
|
AU2001268149B2
(en)
|
2000-06-01 |
2005-08-18 |
University Of North Carolina At Chapel Hill |
Methods and compounds for controlled release of recombinant parvovirus vectors
|
|
US8105825B2
(en)
|
2000-10-03 |
2012-01-31 |
Intrexon Corporation |
Multiple inducible gene regulation system
|
|
WO2002066614A2
(en)
|
2001-02-20 |
2002-08-29 |
Rheogene Holdings, Inc. |
Chimeric retinoid x receptors and their use in a novel ecdysone receptor-based inducible gene expression system
|
|
DK1534738T3
(da)
|
2001-02-20 |
2012-10-01 |
Intrexon Corp |
Nye substitutionsmutantreceptorer og anvendelse heraf i et inducérbart genekpressionssystem på basis af en nuklear receptor
|
|
JP4328094B2
(ja)
|
2001-02-20 |
2009-09-09 |
イントレクソン・コーポレイション |
新規置換突然変異体受容体および核受容体−ベースの誘導性遺伝子発現システムにおけるその使用
|
|
US9493540B2
(en)
|
2001-02-20 |
2016-11-15 |
Intrexon Corporation |
Ecdysone receptor/invertebrate retinoid X receptor-based inducible gene expression system
|
|
WO2002095073A1
(en)
|
2001-05-18 |
2002-11-28 |
Wisconsin Alumni Research Foundation |
Method for the synthesis of dna sequences
|
|
CN103555677B
(zh)
|
2001-11-13 |
2018-01-30 |
宾夕法尼亚大学托管会 |
检测和/或鉴定腺伴随病毒(aav)序列以及分离所鉴定的新型序列的方法
|
|
WO2003052051A2
(en)
|
2001-12-17 |
2003-06-26 |
The Trustees Of The University Of Pennsylvania |
Adeno-associated virus (aav) serotype 8 sequences
|
|
AU2003274397A1
(en)
|
2002-06-05 |
2003-12-22 |
University Of Florida |
Production of pseudotyped recombinant aav virions
|
|
EP1660970A4
(en)
|
2003-08-01 |
2007-02-14 |
Dna Twopointo Inc |
SYSTEMS AND METHODS FOR BIOPOLYMER TECHNOLOGY
|
|
US8005620B2
(en)
|
2003-08-01 |
2011-08-23 |
Dna Twopointo Inc. |
Systems and methods for biopolymer engineering
|
|
DK3211085T3
(da)
|
2003-09-30 |
2021-06-21 |
Univ Pennsylvania |
Klader af adeno-associeret virus (aav), sekvenser, vektorer indeholdende disse og anvendelser deraf
|
|
US20060246079A1
(en)
|
2003-11-14 |
2006-11-02 |
Morrow Phillip R |
Neutralizing human antibodies to anthrax toxin
|
|
US7935510B2
(en)
|
2004-04-30 |
2011-05-03 |
Intrexon Corporation |
Mutant receptors and their use in a nuclear receptor-based inducible gene expression system
|
|
US7838657B2
(en)
|
2004-12-03 |
2010-11-23 |
University Of Massachusetts |
Spinal muscular atrophy (SMA) treatment via targeting of SMN2 splice site inhibitory sequences
|
|
US8999678B2
(en)
|
2005-04-07 |
2015-04-07 |
The Trustees Of The University Of Pennsylvania |
Method of increasing the function of an AAV vector
|
|
PT2420256T
(pt)
|
2005-05-02 |
2016-09-13 |
Genzyme Corp |
Terapia genética para distúrbios neurometabólicos
|
|
US7456683B2
(en)
|
2005-06-09 |
2008-11-25 |
Panasonic Corporation |
Amplitude error compensating device and quadrature skew error compensating device
|
|
US8361977B2
(en)
|
2005-06-23 |
2013-01-29 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for modulation of SMN2 splicing
|
|
US8877187B2
(en)
|
2005-07-25 |
2014-11-04 |
Avianax, Llc |
Therapeutic antibodies for treatment and prophylaxis of transmittable viral diseases
|
|
US7588772B2
(en)
|
2006-03-30 |
2009-09-15 |
Board Of Trustees Of The Leland Stamford Junior University |
AAV capsid library and AAV capsid proteins
|
|
EP2018421B1
(en)
|
2006-04-28 |
2012-12-19 |
The Trustees of the University of Pennsylvania |
Scalable production method for aav
|
|
BRPI0711965A2
(pt)
|
2006-06-07 |
2012-01-24 |
Genzyme Corporation |
terapia de gene para esclerose lateral amiotrófica e outras enfermidades da medula espinal
|
|
DK2066791T3
(da)
|
2006-10-03 |
2012-10-15 |
Genzyme Corp |
Genterapi for amyotrofisk lateralsklerose og andre rygmarvssygdomme
|
|
BRPI0807952A2
(pt)
|
2007-02-20 |
2014-06-10 |
Anaptysbio Inc |
Sistemas de hipermutação somática
|
|
CN102046654A
(zh)
|
2007-03-13 |
2011-05-04 |
胡马斯有限公司 |
针对甲型流感病毒h5n1株系的抗体
|
|
CA2684534C
(en)
|
2007-04-17 |
2017-04-04 |
National Research Council Of Canada |
Constructs for enhancement of gene expression in muscle
|
|
WO2008156763A2
(en)
|
2007-06-15 |
2008-12-24 |
The Board Of Trustees Of The Leland Stanford Junior University |
Human neutralizing monoclonal antibodies to h5n1 influenza a virus
|
|
CN104059143A
(zh)
|
2007-11-12 |
2014-09-24 |
特罗科隆科学有限公司 |
用于对流行性感冒进行治疗以及诊断的组合物以及方法
|
|
MX2010006148A
(es)
|
2007-12-06 |
2011-02-23 |
Dana Farber Cancer Inst Inc |
Anti-cuerpos contra el virus de la influenza y metodos de uso de los mismos.
|
|
ITTO20080204A1
(it)
|
2008-03-17 |
2009-09-18 |
Pomona Biotechnologies Llc |
Anticorpi monoclonali atti a reagire con una pluralita di sottotipi del virus influenzale a
|
|
WO2009121004A2
(en)
|
2008-03-28 |
2009-10-01 |
Sea Lane Biotechnologies, Llc |
Neutralizing molecules to viral antigens
|
|
ITTO20080398A1
(it)
|
2008-05-27 |
2009-11-28 |
Pomona Biotechnologies Llc |
Anticorpi monoclonali aventi proprieta' di cross-neutralizzazione omosubtipica per virus influenzali di tipo a sottotipo h1
|
|
EP2296700A2
(en)
|
2008-06-03 |
2011-03-23 |
Vaxin, Inc. |
Intranasal administration of receptor-binding ligands or genes encoding such ligands as a therapeutic regimen for mitigating infections caused by respiratory pathogens
|
|
US8871207B2
(en)
|
2008-07-25 |
2014-10-28 |
Humabs, LLC |
Neutralizing anti-influenza A virus antibodies and uses thereof
|
|
ES2662519T3
(es)
|
2008-07-25 |
2018-04-06 |
Institute For Research In Biomedicine |
Anticuerpos neutralizantes contra el virus de la gripe A y usos de estos
|
|
WO2010053572A2
(en)
|
2008-11-07 |
2010-05-14 |
Massachusetts Institute Of Technology |
Aminoalcohol lipidoids and uses thereof
|
|
US8211631B2
(en)
|
2008-12-18 |
2012-07-03 |
Wisconsin Alumni Research Foundation |
In vitro model of spinal muscular atrophy
|
|
SG10202109219SA
(en)
*
|
2009-05-02 |
2021-10-28 |
Genzyme Corp |
Gene therapy for neurodegenerative disorders
|
|
WO2010130636A1
(en)
|
2009-05-11 |
2010-11-18 |
Crucell Holland B.V. |
Human binding molecules capable of neutralizing influenza virus h3n2 and uses thereof
|
|
WO2010138263A2
(en)
|
2009-05-28 |
2010-12-02 |
University Of Massachusetts |
Novel aav 's and uses thereof
|
|
IT1395961B1
(it)
|
2009-06-01 |
2012-11-02 |
Pomona Biotechnologies Llc |
Anticorpi monoclonali come medicamento per il trattamento terapeutico e/o profilattico delle infezioni da virus influenzale a (h1n1) di origine suina (s-oiv)
|
|
PT3449926T
(pt)
|
2009-06-17 |
2019-11-12 |
Cold Spring Harbor Laboratory |
Composições e métodos de modulação de excisões de smn2 em um sujeito
|
|
EP2448598B1
(en)
|
2009-06-25 |
2016-03-30 |
MedImmune, LLC |
Swine influenza hemagglutinin variants
|
|
US8598331B2
(en)
|
2009-09-28 |
2013-12-03 |
The University Of British Columbia |
CLDN5 mini-promoters
|
|
US9315825B2
(en)
|
2010-03-29 |
2016-04-19 |
The Trustees Of The University Of Pennsylvania |
Pharmacologically induced transgene ablation system
|
|
SG10201908848RA
(en)
|
2010-03-29 |
2019-10-30 |
Univ Pennsylvania |
Pharmacologically induced transgene ablation system
|
|
US8927514B2
(en)
|
2010-04-30 |
2015-01-06 |
City Of Hope |
Recombinant adeno-associated vectors for targeted treatment
|
|
JP6091435B2
(ja)
|
2011-02-22 |
2017-03-08 |
カリフォルニア インスティチュート オブ テクノロジー |
アデノ随伴ウイルス（ａａｖ）ベクターを用いたタンパク質の送達
|
|
EP2699688A1
(en)
|
2011-04-20 |
2014-02-26 |
The Trustees Of The University Of Pennsylvania |
Regimens and compositions for aav-mediated passive immunization of airborne pathogens
|
|
US20140127749A1
(en)
|
2011-04-21 |
2014-05-08 |
Arizona Borad Of Regents, A Body Corporate Of The State Of Arizona Acting For And On Behalf Of Arizo |
Methods of protein production and compositions thereof
|
|
PT2717893T
(pt)
|
2011-06-08 |
2019-08-20 |
Translate Bio Inc |
Composições de nanopartículas lipídicas e métodos para transferência de arnm
|
|
FR2977562B1
(fr)
|
2011-07-06 |
2016-12-23 |
Gaztransport Et Technigaz |
Cuve etanche et thermiquement isolante integree dans une structure porteuse
|
|
US8961978B2
(en)
|
2011-07-14 |
2015-02-24 |
Crucell Holland B.V. |
Human binding molecules capable of neutralizing influenza A viruses of phylogenetic group 1 and phylogenetic group 2 and influenza B viruses
|
|
WO2013114885A1
(en)
|
2012-01-31 |
2013-08-08 |
Osaka University |
Human monoclonal antibodies broadly protective against influenza b virus and methods of using the same
|
|
WO2013123503A1
(en)
*
|
2012-02-17 |
2013-08-22 |
The Children's Hospital Of Philadelphia |
Aav vector compositions and methods for gene transfer to cells, organs and tissues
|
|
KR102050615B1
(ko)
|
2012-03-08 |
2019-11-29 |
얀센 백신스 앤드 프리벤션 비.브이. |
인플루엔자 b 바이러스들에 결합하고 중화할 수 있는 인간 결합 분자 및 그 용도
|
|
EP2834259A4
(en)
*
|
2012-04-02 |
2016-08-24 |
Moderna Therapeutics Inc |
MODIFIED POLYNUCLEOTIDES
|
|
WO2013155222A2
(en)
|
2012-04-10 |
2013-10-17 |
The Regents Of The University Of California |
Brain-specific enhancers for cell-based therapy
|
|
RU2683497C2
(ru)
|
2012-04-18 |
2019-03-28 |
Дзе Чилдрен'З Хоспитал Оф Филадельфия |
Композиция и способы высокоэффективного переноса генов с помощью вариантов капсида aav
|
|
US20150126589A1
(en)
|
2012-06-08 |
2015-05-07 |
Ethris Gmbh |
Pulmonary Delivery of Messenger RNA
|
|
WO2013190059A1
(en)
|
2012-06-21 |
2013-12-27 |
Association Institut De Myologie |
Widespread gene delivery of gene therapy vectors
|
|
EP2880053B8
(en)
|
2012-08-01 |
2020-04-15 |
Ikaika Therapeutics, LLC |
Mitigating tissue damage and fibrosis via anti-ltbp4 antibody
|
|
US9719106B2
(en)
|
2013-04-29 |
2017-08-01 |
The Trustees Of The University Of Pennsylvania |
Tissue preferential codon modified expression cassettes, vectors containing same, and uses thereof
|
|
US10821154B2
(en)
*
|
2013-05-01 |
2020-11-03 |
Genzyme Corporation |
Compositions and methods for treating spinal muscular atrophy
|
|
BR112016001592A2
(pt)
|
2013-07-26 |
2017-11-28 |
Univ Iowa Res Found |
métodos e composições para o tratamento de doenças cerebrais
|
|
US9585971B2
(en)
*
|
2013-09-13 |
2017-03-07 |
California Institute Of Technology |
Recombinant AAV capsid protein
|
|
CN105658800A
(zh)
*
|
2013-10-22 |
2016-06-08 |
夏尔人类遗传性治疗公司 |
Mrna的cns递送及其用途
|
|
CN105745326A
(zh)
|
2013-10-24 |
2016-07-06 |
优尼科Ip有限公司 |
用于基因治疗神经疾病的aav-5假型载体
|
|
EP3107582A4
(en)
|
2014-02-19 |
2018-02-14 |
Emergent BioSolutions Canada Inc. |
Ebola monoclonal antibodies
|
|
WO2015164757A1
(en)
|
2014-04-25 |
2015-10-29 |
Oregon Health & Science University |
Methods of viral neutralizing antibody epitope mapping
|
|
WO2015164723A1
(en)
|
2014-04-25 |
2015-10-29 |
The Trustees Of The University Of Pennsylvania |
Methods and compositions for treating metastatic breast cancer and other cancers in the brain
|
|
US11555059B2
(en)
|
2014-04-25 |
2023-01-17 |
The Trustees Of The University Of Pennsylvania |
LDLR variants and their use in compositions for reducing cholesterol levels
|
|
WO2015168666A2
(en)
|
2014-05-02 |
2015-11-05 |
Genzyme Corporation |
Aav vectors for retinal and cns gene therapy
|
|
DK3142750T3
(da)
|
2014-05-13 |
2020-09-14 |
Univ Pennsylvania |
Sammensætninger omfattende aav, som udtrykker dobbelt-antistofkonstrukter og anvendelser deraf
|
|
KR20230067694A
(ko)
|
2014-09-24 |
2023-05-16 |
시티 오브 호프 |
고효율 게놈 편집을 위한 아데노-관련 바이러스 벡터 변이체 및 이의 방법
|
|
CA2963470A1
(en)
|
2014-10-03 |
2016-04-07 |
Massachusetts Institute Of Technology |
Antibodies that bind ebola glycoprotein and uses thereof
|
|
PH12017501216B1
(en)
|
2015-02-05 |
2023-05-24 |
Janssen Vaccines And Prevention B V |
Binding molecules directed against influenza hemagglutinin and uses thereof
|
|
US11535665B2
(en)
|
2015-05-13 |
2022-12-27 |
The Trustees Of The University Of Pennsylvania |
AAV-mediated expression of anti-influenza antibodies and methods of use thereof
|
|
CA3003435A1
(en)
|
2015-10-28 |
2017-05-04 |
The Trustees Of The University Of Pennsylvania |
Intrathecal administration of adeno-associated-viral vectors for gene therapy
|
|
WO2017100676A1
(en)
|
2015-12-11 |
2017-06-15 |
The Trustees Of The University Of Pennsylvania |
Scalable purification method for aav8
|
|
US11098286B2
(en)
|
2015-12-11 |
2021-08-24 |
The Trustees Of The University Of Pennsylvania |
Scalable purification method for AAV9
|
|
EP3387118B1
(en)
|
2015-12-11 |
2022-04-06 |
The Trustees Of The University Of Pennsylvania |
Scalable purification method for aavrh10
|
|
US11015173B2
(en)
|
2015-12-11 |
2021-05-25 |
The Trustees Of The University Of Pennsylvania |
Scalable purification method for AAV1
|
|
WO2017106354A1
(en)
|
2015-12-14 |
2017-06-22 |
The Trustees Of The University Of Pennsylvania |
Adeno-associated viral vectors useful in treatment of spinal muscular atropy
|
|
US20180363000A1
(en)
|
2015-12-14 |
2018-12-20 |
The Trustees Of The University Of Pennsylvania |
Aav-anti pcsk9 antibody constructs and uses thereof
|
|
US20190002915A1
(en)
|
2015-12-14 |
2019-01-03 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for regulatable antibody expression
|
|
WO2017136500A1
(en)
|
2016-02-03 |
2017-08-10 |
The Trustees Of The University Of Pennsylvania |
Gene therapy for treating mucopolysaccharidosis type i
|
|
US11698377B2
(en)
|
2016-08-15 |
2023-07-11 |
Genzyme Corporation |
Methods for detecting AAV
|
|
WO2018057916A1
(en)
|
2016-09-24 |
2018-03-29 |
The Trustees Of The University Of Pennsylvania |
Novel humanized anti-ebola antibodies useful in preventing ebola infections
|
|
JOP20190200A1
(ar)
*
|
2017-02-28 |
2019-08-27 |
Univ Pennsylvania |
تركيبات نافعة في معالجة ضمور العضل النخاعي
|
|
SI3589730T1
(sl)
|
2017-02-28 |
2024-04-30 |
The Trustees Of The University Of Pennsylvania |
Adeno-povezan virus (AAV) clade F vektor in njihova uporaba
|
|
US10786568B2
(en)
|
2017-02-28 |
2020-09-29 |
The Trustees Of The University Of Pennsylvania |
AAV mediated influenza vaccines
|